Literature DB >> 17076868

Too much ado about propensity score models? Comparing methods of propensity score matching.

Onur Baser1.   

Abstract

OBJECTIVE: A large number of possible techniques are available when conducting matching procedures, yet coherent guidelines for selecting the most appropriate application do not yet exist. In this article we evaluate several matching techniques and provide a suggested guideline for selecting the best technique.
METHODS: The main purpose of a matching procedure is to reduce selection bias by increasing the balance between the treatment and control groups. The following approach, consisting of five quantifiable steps, is proposed to check for balance: 1) Using two sample t-statistics to compare the means of the treatment and control groups for each explanatory variable; 2) Comparing the mean difference as a percentage of the average standard deviations; 3) Comparing percent reduction of bias in the means of the explanatory variables before and after matching; 4) Comparing treatment and control density estimates for the explanatory variables; and 5) Comparing the density estimates of the propensity scores of the control units with those of the treated units. We investigated seven different matching techniques and how they performed with regard to proposed five steps. Moreover, we estimate the average treatment effect with multivariate analysis and compared the results with the estimates of propensity score matching techniques. The Medstat MarketScan Data Base provided data for use in empirical examples of the utility of several matching methods. We conducted nearest neighborhood matching (NNM) analyses in seven ways: replacement, 2 to 1 matching, Mahalanobis matching (MM), MM with caliper, kernel matching, radius matching, and the stratification method.
RESULTS: Comparing techniques according to the above criteria revealed that the choice of matching has significant effects on outcomes. Patients with asthma are compared with patients without asthma and cost of illness ranged from 2040 dollars to 4463 dollars depending on the type of matching. After matching, we looked at the insignificant differences or larger P-values in the mean values (criterion 1); low mean differences as a percentage of the average standard deviation (criterion 2); 100% reduction bias in the means of explanatory variables (criterion 3); and insignificant differences when comparing the density estimates of the treatment and control groups (criterion 4 and criterion 5). Mahalanobis matching with caliber yielded the better results according all five criteria (Mean = 4463 dollars, SD = 3252 dollars). We also applied multivariate analysis over the matched sample. This decreased the deviation in cost of illness estimates more than threefold (Mean = 4456 dollars, SD = 996 dollars).
CONCLUSION: Sensitivity analysis of the matching techniques is especially important because none of the proposed methods in the literature is a priori superior to the others. The suggested joint consideration of propensity score matching and multivariate analysis offers an approach to assessing the robustness of the estimates.

Entities:  

Mesh:

Year:  2006        PMID: 17076868     DOI: 10.1111/j.1524-4733.2006.00130.x

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  75 in total

Review 1.  Measuring the impact and outcomes of maternal child health federal programs.

Authors:  Yhenneko J Taylor; Mary A Nies
Journal:  Matern Child Health J       Date:  2013-07

2.  The challenge of selection bias and confounding in palliative care research.

Authors:  Helene Starks; Paula Diehr; J Randall Curtis
Journal:  J Palliat Med       Date:  2009-02       Impact factor: 2.947

3.  Does medication adherence following a copayment increase differ by disease burden?

Authors:  Virginia Wang; Chuan-Fen Liu; Christopher L Bryson; Nancy D Sharp; Matthew L Maciejewski
Journal:  Health Serv Res       Date:  2011-06-20       Impact factor: 3.402

4.  Recurrence and survival outcomes after anatomic segmentectomy versus lobectomy for clinical stage I non-small-cell lung cancer: a propensity-matched analysis.

Authors:  Rodney J Landreneau; Daniel P Normolle; Neil A Christie; Omar Awais; Joseph J Wizorek; Ghulam Abbas; Arjun Pennathur; Manisha Shende; Benny Weksler; James D Luketich; Matthew J Schuchert
Journal:  J Clin Oncol       Date:  2014-06-30       Impact factor: 44.544

5.  Applying propensity score methods in medical research: pitfalls and prospects.

Authors:  Zhehui Luo; Joseph C Gardiner; Cathy J Bradley
Journal:  Med Care Res Rev       Date:  2010-05-04       Impact factor: 3.929

6.  Healthcare costs associated with switching from brand to generic levothyroxine.

Authors:  Michael Katz; Joseph Scherger; Scott Conard; Leslie Montejano; Stella Chang
Journal:  Am Health Drug Benefits       Date:  2010-03

7.  Sex differences in the prevalence of metabolic syndrome and its components in hypopituitary patients: comparison with an age- and sex-matched nationwide control group.

Authors:  Ah Reum Khang; Eu Jeong Ku; Ye An Kim; Eun Roh; Jae Hyun Bae; Tae Jung Oh; Sang Wan Kim; Chan Soo Shin; Seong Yeon Kim; Jung Hee Kim
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

8.  Estimating the cost of type 1 diabetes in the U.S.: a propensity score matching method.

Authors:  Betty Tao; Massimo Pietropaolo; Mark Atkinson; Desmond Schatz; David Taylor
Journal:  PLoS One       Date:  2010-07-09       Impact factor: 3.240

9.  Pathologic Predictors of Survival During Lymph Node Dissection for Metastatic Renal-Cell Carcinoma: Results From a Multicenter Collaboration.

Authors:  Juan Chipollini; E Jason Abel; Charles C Peyton; David C Boulware; Jose A Karam; Vitaly Margulis; Viraj A Master; Kamran Zargar-Shoshtari; Surena F Matin; Wade J Sexton; Jay D Raman; Christopher G Wood; Philippe E Spiess
Journal:  Clin Genitourin Cancer       Date:  2017-10-17       Impact factor: 2.872

10.  Metabolic screening after the American Diabetes Association's consensus statement on antipsychotic drugs and diabetes.

Authors:  Elaine H Morrato; John W Newcomer; Siddhesh Kamat; Onur Baser; James Harnett; Brian Cuffel
Journal:  Diabetes Care       Date:  2009-02-24       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.